APEMESH II - Perineal Reconstruction

January 31, 2024 updated by: Elisa Mäkäräinen, University of Oulu

Apemesh II - Perineal Reconstruction With Mesh Enhanced Gluteus Plasty

The objective of this pilot study is to assess the safety, functional outcome, feasibility and the potential benefits of synthetic mesh strip and gluteus flap reconstruction in perineum in case-control setting.

Study Overview

Status

Completed

Conditions

Detailed Description

Several studies have reported over 30% morbidity with perineal wound healing after abdominoperineal resection. Preoperative radiotherapy seems to be a strong predictor for perineal complications. Musculocutaneus flaps and use of biological mesh seem to minimize perineal morbidity.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Oulu, Finland
        • Oulu University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Curative intent abdominoperineal resection and permanent colostomy

Exclusion Criteria:

  • Patient with a comorbid illness or condition that would preclude the use of surgery (ASA 4- 5)
  • Immunosupression (cortisone >10mg/day) or severe malnutrition (BMI <20)
  • Diabetes with 1 or more organ damage
  • Dialysis treatment
  • Hepatic cirrhosis Child-Bugh B-C
  • Potentially curable resection not possible
  • Patient undergoing emergency procedures
  • Metastatic disease
  • Vaginal resection, pelvic exenteration and sacrum resection
  • Vaginal perforation
  • Pelvic abscess or perforated tumor
  • Pregnant or suspected pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gluteus plasty enhanced with Progrip self gripping mesh
All study patietns will have a gluteus enhanced plasty after abdominoperineal reconstruction.
Intervention group will be compared to historical patients in a case-control setting. Intervention group will have a mesh enhanced gluteus plasty made to reconstruct perineum after abdominoperineal resection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: 30 days
Comprehensive complication index
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical site infections
Time Frame: 30 days
Surgical site infections
30 days
Reoperation rate
Time Frame: 30 days
Reoperation rate
30 days
Operative time
Time Frame: 30 days
Operative time to reconstruct perineum
30 days
Length of hospital stay
Time Frame: 30 days
Primary length of stay at the hospital
30 days
Costs of treatment materials
Time Frame: 30 days
Costs of treatment materials
30 days
Total perineal healing time
Time Frame: 1 year
Time from operation to complete perineal healing
1 year
Perineal fistula
Time Frame: 30 days
Perineal sinus or fistula
30 days
Perineal hernia
Time Frame: 12 months
Perineal hernia incidence
12 months
Gluteus muscle function measured by time stands test
Time Frame: 12 months
Gluteus muscle function measured by time stands test
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Tero Rautio, M.D. Ph.D., Oulu University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 19, 2021

Primary Completion (Actual)

March 1, 2022

Study Completion (Actual)

March 1, 2022

Study Registration Dates

First Submitted

February 22, 2021

First Submitted That Met QC Criteria

March 2, 2021

First Posted (Actual)

March 3, 2021

Study Record Updates

Last Update Posted (Estimated)

February 1, 2024

Last Update Submitted That Met QC Criteria

January 31, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectal Cancer

Clinical Trials on Gluteus plasty enhanced with Progrip self gripping mesh

3
Subscribe